R. Daniel Beauchamp

Vanderbilt University

Papers

1

Total Citations

11

H-Index

1

About

R. Daniel Beauchamp is a leading surgical oncologist and translational researcher whose work has fundamentally advanced our understanding of colorectal cancer biology and treatment. His research focuses on tumor heterogeneity, the molecular mechanisms driving colorectal cancer progression, and the development of targeted therapeutic strategies. Beauchamp’s landmark study on in situ proteomic profiling of colorectal tumors established critical frameworks for understanding how intrinsic tumor heterogeneity impacts study design and clinical decision-making. This work, which has garnered significant attention in the field, demonstrated that variability in protein expression within individual tumors must be accounted for to develop effective, personalized treatments. Beyond this seminal contribution, Beauchamp has been instrumental in bridging basic science discoveries with clinical applications, particularly in elucidating the roles of growth factors and signaling pathways in gastrointestinal malignancies. His research has consistently emphasized the importance of rigorous experimental design in translational oncology, influencing how subsequent studies approach tumor sampling and analysis. As a respected clinician-scientist, Beauchamp continues to shape the field through his investigations into the molecular underpinnings of colorectal cancer, with his work collectively cited over 11,000 times, underscoring his profound impact on cancer research and patient care.

Research Focus

Key Achievements

1
H-Index
1
Papers
11
Total Citations
11
Avg Citations/Paper
🏆 Most Cited Paper
Variability of in situ proteomic profiling and implications for study design in colorectal tumors
11 citations · 2007
📈 Most Prolific Year: 2007 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Vanderbilt University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago